课题基金 / 基金详情

Advanced Imaging Core

Advanced Imaging Core
先进的成像核心
批准号:
10337321
负责人:
John J Lemasters
金额:
$21.01万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-04-03 至 2025-01-31

项目摘要

项目成果

John J Lemasters的其他基金

相似基金

相关文献

中文摘要
翻译
高级成像核心-项目摘要 消化和肝病(CDLD)高级成像核心提供设备、专业知识和 对CDLD调查人员进行最先进的基于细胞和组织成像的培训,包括共焦、多光子 以及活的和固定的细胞和组织的超分辨率显微镜,活体成像和自动成像 组织学切片。先进成像核心包含以下主要显微镜系统:1)蔡司LSM 配备相干变色龙多光子激光器、类星体光谱的880 NLO多光子/共焦系统 探测和AiryScan超分辨率能力;2)奥林巴斯FluoView FV1200多光子显微镜,具有 光谱物理迈泰深见激光和硅油光学技术用于活体成像;3)奥林巴斯FluoView FV 10i LiV水浸光学活细胞共聚焦显微镜;4)蔡司LSM 510元共聚焦显微镜;5) BD BioSciences Carv II用于视频率成像的圆盘扫描共聚焦显微镜;6)蔡司Axiovert 200m 宽场荧光显微镜;7)Perkin-Elmer Vectra Polaris自动定量病理学 成像系统。除了为组织切片定制的Vectra Polaris外,所有显微镜都是 配备用于温度和气相控制的环境室,以实现非破坏性3D 活细胞、组织和生物体的成像。主要应用包括1)参数的活细胞成像- 用于监测离子、电位、自由基产生、吡啶核苷酸还原、 膜通透性、细胞活力(细胞凋亡和坏死)和荧光的亚微米分布 蛋白质和其他荧光记者;2)免疫细胞化学组织切片的高分辨率成像 和荧光蛋白分布;3)荧光共振能量转移(FRET)和DuoLink 表征和量化特定分子之间的相互作用;4)活体显微镜 微循环、白细胞边际化、线粒体极化和通透性、自由基生成、基因 在活体动物中的表达和其他参数;以及5)高通量、定量多路复用成像 常规和免疫染色的临床和研究标本。标本所需的辅助设备 还提供了准备工作。通过本部门可获得有关电子显微镜和扫描电子显微镜的咨询和服务 病理学与检验医学系。计算机工作站提供离线图像处理/分析(ImageJ 斐济、Metamorph、IPLab和其他软件)。高级成像核心服务提供培训和帮助 以促进CDLD个别调查人员的成功。
英文摘要
Advanced Imaging Core – Project Summary The COBRE in Digestive & Liver Disease (CDLD) Advanced Imaging Core provides equipment, expertise and training to CDLD investigators for state-of-the-art cell- and tissue-based imaging, including confocal, multiphoton and super-resolution microscopy of live and fixed cells and tissues, intravital imaging and automated imaging of histological slides. The Advanced Imaging Core houses the following major microscope systems: 1) Zeiss LSM 880 NLO multiphoton/confocal system equipped with a Coherent Chameleon multi-photon laser, Quasar spectral detection and Airyscan super-resolution capability; 2) Olympus Fluoview FV1200 multiphoton microscope with SpectraPhysics MaiTai DeepSee laser and silicone oil optics for intravital imaging; 3) Olympus Fluoview FV 10i LIV live cell confocal microscope with water immersion optics; 4) Zeiss LSM 510 META confocal microscope; 5) BD BioSciences CARV II disk-scanning confocal microscope for video-rate imaging; 6) Zeiss Axiovert 200M widefield fluorescence microscope; and 7) Perkin-Elmer Vectra Polaris Automated Quantitative Pathology Imaging System. Except for Vectra Polaris which is customized for histological slides, all microscopes are equipped with environmental chambers for temperature and gas phase control to allow non-destructive 3D imaging of living cells, tissues and organisms. Major applications include 1) live cell imaging of parameter- sensitive fluorophores to monitor ions, electrical potentials, radical generation, pyridine nucleotide reduction, membrane permeability, cell viability (apoptosis and necrosis), and the submicron distribution of fluorescent proteins and other fluorescent reporters; 2) high resolution imaging of tissue sections for immunocytochemistry and fluorescent protein distribution; 3) fluorescence resonance energy transfer (FRET) and DuoLink to characterize and quantify interactions between specific molecules; 4) intravital microscopy to monitor microcirculation, leukocyte margination, mitochondrial polarization and permeability, radical generation, gene expression and other parameters in living animals; and 5) high throughput, quantitative multiplexed imaging of conventionally and immunostained clinical and research specimens. Ancillary equipment required for specimen preparation is also provided. Consultation and services for TEM and SEM are available through the Department of Pathology & Laboratory Medicine. Computer workstations provide offline image processing/analysis (ImageJ FIJI, Metamorph, IPLab and other software). Advanced Imaging Core services provide training and assistance to promote the success of individual CDLD investigators.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cell and Molecular Imaging Core
Mechanisms of Mitochondrial Iron Uptake: New Therapeutic Targets in Hepatotoxicity
Mechanisms of Mitochondrial Iron Uptake: New Therapeutic Targets in Hepatotoxicity
Cell and Molecular Imaging Core
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: